Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryoichi Imamura

Showing results (191-200 of 206) with videos related to

Pageof 21
Sort By:
International Journal of Urology : Official Journal of the Japanese Urological Association|February 20, 2022
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinomaYoko Koh, Kosuke Nakano, Kotoe Katayama, et al.
The Prostate|August 29, 2017
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimensTakuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.
BMC Nephrology|June 6, 2023
Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version)Hiroshi Harada, Nobuyuki Fukuzawa, Toyofumi Abe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 9, 2026
Evaluation of the Association between Age, Sex and d-Amino Acid-Based Estimation of Glomerular Filtration RateShota Fukae, Shinsuke Sakai, Ryo Tanaka, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
International Journal of Clinical Oncology|July 13, 2022
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective studyTaigo Kato, Kazutoshi Fujita, Takafumi Minami, et al.
Cancer Science|March 16, 2022
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinomaKosuke Nakano, Yoko Koh, Gaku Yamamichi, et al.
Cancer Science|December 12, 2018
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Masashi Fujita, et al.
Scientific Reports|April 12, 2020
Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinomaAtsunari Kawashima, Takayuki Kanazawa, Yujiro Kidani, et al.
International Journal of Cancer|April 11, 2022
High-fat diet promotes prostate cancer growth through histamine signalingMakoto Matsushita, Kazutoshi Fujita, Koji Hatano, et al.
Pageof 21

Showing results (191-200 of 206) with videos related to

Sort By:
Pageof 21
International Journal of Urology : Official Journal of the Japanese Urological Association|February 20, 2022
Early dynamics of circulating tumor DNA predict clinical response to immune checkpoint inhibitors in metastatic renal cell carcinomaYoko Koh, Kosuke Nakano, Kotoe Katayama, et al.
The Prostate|August 29, 2017
Peripheral blood monocyte count reflecting tumor-infiltrating macrophages is a predictive factor of adverse pathology in radical prostatectomy specimensTakuji Hayashi, Kazutoshi Fujita, Satoshi Nojima, et al.
BMC Nephrology|June 6, 2023
Development and nationwide validation of kidney graft injury markers using urinary exosomes and microvesicles (complete English translation of the Japanese version)Hiroshi Harada, Nobuyuki Fukuzawa, Toyofumi Abe, et al.
Clinical Journal of the American Society of Nephrology : CJASN|June 9, 2026
Evaluation of the Association between Age, Sex and d-Amino Acid-Based Estimation of Glomerular Filtration RateShota Fukae, Shinsuke Sakai, Ryo Tanaka, et al.
Cancer Science|March 20, 2019
Diagnostic potential of TERT promoter and FGFR3 mutations in urinary cell-free DNA in upper tract urothelial carcinomaYujiro Hayashi, Kazutoshi Fujita, Kyosuke Matsuzaki, et al.
International Journal of Clinical Oncology|July 13, 2022
Real-world efficacy and safety of nivolumab plus ipilimumab in untreated metastatic renal cell carcinoma, and the impact of previous nephrectomy on clinical outcome: Japanese multi-institutional retrospective studyTaigo Kato, Kazutoshi Fujita, Takafumi Minami, et al.
Cancer Science|March 16, 2022
Perioperative circulating tumor DNA enables the identification of patients with poor prognosis in upper tract urothelial carcinomaKosuke Nakano, Yoko Koh, Gaku Yamamichi, et al.
Cancer Science|December 12, 2018
Clinical significance of the mutational landscape and fragmentation of circulating tumor DNA in renal cell carcinomaYoshiyuki Yamamoto, Motohide Uemura, Masashi Fujita, et al.
Scientific Reports|April 12, 2020
Tumour grade significantly correlates with total dysfunction of tumour tissue-infiltrating lymphocytes in renal cell carcinomaAtsunari Kawashima, Takayuki Kanazawa, Yujiro Kidani, et al.
International Journal of Cancer|April 11, 2022
High-fat diet promotes prostate cancer growth through histamine signalingMakoto Matsushita, Kazutoshi Fujita, Koji Hatano, et al.
Pageof 21